Prostaglandin-endoperoxide synthase (COX)

Central cyclooxygenase (COX) enzymes, specifically the isoforms Prostaglandin-endoperoxide synthase 1 (COX-1) and 2 (COX-2), are critical mediators of the inflammatory and nociceptive response within the central nervous system (Source: StatPearls, PMID: 30020704). These enzymes catalyze the rate-limiting step in the production of prostaglandins, such as PGE2, which act on the hypothalamus to induce fever and sensitize spinal neurons to pain signals (Source: PubMed, PMID: 12432394). While non-steroidal anti-inflammatory drugs (NSAIDs) inhibit COX enzymes both peripherally and centrally, acetaminophen (paracetamol) is uniquely characterized by its predominant action on central cyclooxygenase activity (Source: Science, PMID: 12242445). This central selectivity allows acetaminophen to provide analgesia and antipyresis without the significant peripheral anti-inflammatory effects or gastrointestinal side effects typical of NSAIDs. Research has also suggested the existence of a central-specific splice variant, COX-3, as a potential target for acetaminophen, although its functional significance in humans remains a subject of scientific debate (Source: PNAS, PMID: 12242445). Therapeutic modulation of central COX is essential for managing acute and chronic pain, yet it requires careful consideration of safety profiles, including potential hepatotoxicity from acetaminophen and cardiovascular risks associated with selective COX-2 inhibition (Source: NIH, PubChem).

Other names

CyclooxygenasePTGSProstaglandin G/H synthaseCentral COXCOX-3Central cyclooxygenase enzymes

Inhibition of the cyclooxygenase (COX) activity of prostaglandin-endoperoxide synthase, which prevents the conversion of arachidonic acid to prostaglandin G2 (PGG2) and subsequently prostaglandin H2 (PGH2) (Source: StatPearls, PMID: 30020704). In the central nervous system, this reduces the synthesis of PGE2, leading to antipyretic and analgesic effects (Source: PubMed, PMID: 12432394).